staurosporine aglycone has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies
staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oyama, Y | 1 |
| Nagao, S | 1 |
| Na, L | 1 |
| Yanai, K | 1 |
| Umebayashi, M | 1 |
| Nakamura, K | 1 |
| Nagai, S | 1 |
| Fujimura, A | 1 |
| Yamasaki, A | 1 |
| Nakayama, K | 1 |
| Morisaki, T | 1 |
| Onishi, H | 1 |
1 other study available for staurosporine aglycone and Carcinoma, Ductal, Pancreatic
| Article | Year |
|---|---|
TrkB/BDNF Signaling Could Be a New Therapeutic Target for Pancreatic Cancer.
Topics: Brain-Derived Neurotrophic Factor; Carbazoles; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell | 2021 |